Apyx Medical (APYX) Corporation announces it has received 510(k) clearance from the U.S. Food and Drug Administration for the AYON Body Contouring System. The Company is actively preparing for a commercial launch of AYON with key surgeons in critical geographies starting in the second half of 2025.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APYX: